AORT: Artivion, Inc. Stock

by  •  • Comments Off on AORT: Artivion, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 845.46
Enterprise Value ($M) 1,093.50
Book Value ($M) 281.78
Book Value / Share 6.76
Price / Book 3.00
NCAV ($M) -229.95
NCAV / Share -5.51
Price / NCAV -3.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.05
Return on Assets (ROA) -0.04
Return on Equity (ROE) -0.11

Liquidity (mrq)
Quick Ratio 3.43
Current Ratio 4.85

Balance Sheet (mrq) ($M)
Current Assets 280.67
Assets 792.40
Liabilities 510.62
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 354.00
Operating Income -8.35
Net Income -30.69
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 18.82
Cash from Investing -0.50
Cash from Financing 0.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-11 13G Perceptive Advisors Llc 5.80
02-14 13G/A Macquarie Group Ltd 7.00 7.92
02-13 13G/A Vanguard Group Inc 6.41 -6.35
02-12 13G/A Morgan Stanley 5.80 8.50
02-08 13G/A Wellington Management Group Llp 5.99 8.10
01-22 13G/A BlackRock Inc. 16.70 -5.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 o TRANSITION REPORT PURSUANT
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 o TRANSITION REPORT PURSUANT TO S
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 o TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 13,897 61,254 22.69
2024-04-25 26,332 138,905 18.96
2024-04-24 35,736 172,979 20.66
2024-04-23 16,812 133,016 12.64
2024-04-22 20,356 122,183 16.66

(click for more detail)

Similar Companies
ALUR – Allurion Technologies Inc. AVNS – Avanos Medical, Inc.
BAX – Baxter International Inc.


Financial data and stock pages provided by
Fintel.io